Asset Management One Co. Ltd. Buys 4,386 Shares of The Clorox Company (NYSE:CLX)

Posted by on Jul 11th, 2023

Asset Management One Co. Ltd. grew its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 4.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 107,281 shares of the company’s stock after purchasing an additional 4,386 shares during the period. Asset Management One Co. Ltd.’s holdings in Clorox were worth $16,976,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. American Century Companies Inc. grew its stake in shares of Clorox by 18.0% in the 1st quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock worth $1,157,000 after buying an additional 1,269 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Clorox by 6.8% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after purchasing an additional 1,044 shares in the last quarter. Cibc World Market Inc. increased its stake in Clorox by 276.6% during the 1st quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after purchasing an additional 6,844 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Clorox by 0.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock worth $95,073,000 after acquiring an additional 5,145 shares during the last quarter. Finally, Blair William & Co. IL lifted its position in Clorox by 81.1% in the 1st quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after acquiring an additional 10,981 shares in the last quarter. Institutional investors own 79.37% of the company’s stock.

Clorox Stock Performance

CLX opened at $156.45 on Tuesday. The company has a current ratio of 0.87, a quick ratio of 0.51 and a debt-to-equity ratio of 14.40. The company has a market cap of $19.34 billion, a price-to-earnings ratio of 269.75, a PEG ratio of 2.21 and a beta of 0.30. The company’s 50 day moving average is $161.03 and its 200 day moving average is $155.10. The Clorox Company has a 12-month low of $124.58 and a 12-month high of $178.21.

Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Tuesday, May 2nd. The company reported $1.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.29. Clorox had a net margin of 1.03% and a return on equity of 114.67%. The company had revenue of $1.92 billion for the quarter, compared to the consensus estimate of $1.82 billion. During the same quarter last year, the firm posted $1.31 earnings per share. The firm’s revenue was up 5.9% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 4.56 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Royal Bank of Canada upped their price objective on Clorox from $137.00 to $151.00 in a research report on Wednesday, May 3rd. Bank of America boosted their target price on Clorox from $130.00 to $140.00 in a research report on Wednesday, May 3rd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $147.00 to $149.00 in a report on Tuesday, April 18th. UBS Group lifted their price target on shares of Clorox from $148.00 to $162.00 in a research note on Wednesday, May 3rd. Finally, Barclays lifted their price target on shares of Clorox from $118.00 to $124.00 in a research note on Sunday, May 14th. Seven analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $148.54.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.